Cytokine Release Syndrome (CRS) is a severe systemic inflammatory response that can occur after certain cancer treatments, especially those involving immunotherapy. It is characterized by the excessive release of cytokines, which are signaling proteins that mediate and regulate immunity, inflammation, and hematopoiesis.
